GSA Capital Partners »

Belite Bio shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $234k 1.5k 159.95

More positions owned by GSA Capital Partners

Ishares Tr Fltg Rate Nt Etf (FLOT)
NVIDIA Corporation (NVDA)
Remitly Global (RELY)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Cheniere Energy Com New (LNG)
Mobileye Global Common Class A (MBLY)
EOG Resources (EOG)
Pfizer (PFE)
Match Group (MTCH)
Frontline (FRO)
Tutor Perini Corporation (TPC)
Delek Us Holdings (DK)
Allstate Corporation (ALL)
Microsoft Corporation (MSFT)
Costco Wholesale Corporation (COST)

View all positions for GSA Capital Partners

Top funds holding Belite Bio

Darwin Global Management
RA Capital Management
Rtw Investments
Eventide Asset Management
Point72 Asset Management
Deerfield Management Company
Marshall Wace
UBS Group
MPM Oncology Impact Management
Holocene Advisors
Western Standard
Perceptive Advisors
Goldman Sachs Group
Soleus Capital Management
ADAR1 Capital Management

View all funds holding Belite Bio